Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study

INTRODUCTION: Albiglutide, a selective once-weekly glucagon-like peptide-1 receptor agonist, is being developed for the treatment of type 2 diabetes mellitus. Albiglutide’s effect on cardiac repolarization (QTc interval) was assessed in a randomized, double-blind, placebo-controlled, parallel-group...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Darpo, Borje, Zhou, Meijian, Matthews, Jessica, Zhi, Hui, Young, Malcolm A., Perry, Caroline, Reinhardt, Rickey R.
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4065291/
https://ncbi.nlm.nih.gov/pubmed/24510375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0055-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars